Benucci M - Search Results

1

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience.

Infantino M, Morena L, Di Pietro MA, Romanin B, Cimolato B, Rocca BAL, Tunnera S, Modi G, Tilli M, Grossi V, Lari B, Cerutti H, Tesi G, Anrò V, Cartocci A, Benucci M, Veneziani F, Casprini P, Manfredi M. Infantino M, et al. Among authors: benucci m. Clin Immunol. 2022 Sep;242:109091. doi: 10.1016/j.clim.2022.109091. Epub 2022 Aug 6. Clin Immunol. 2022. PMID: 35944880 Free PMC article.

2

Plasminogen activator and receptor in osteoarthritis.

Serni U, Fibbi G, Anichini E, Zamperini A, Pucci M, Mannoni A, Matucci A, Benucci M, Del Rosso A, Del Rosso M. Serni U, et al. Among authors: benucci m. J Rheumatol Suppl. 1995 Feb;43:120-2. J Rheumatol Suppl. 1995. PMID: 7752114 Review.

3

[Systemic lupus erythematosus: the first Italian prevalence study].

Benucci M, Li Gobbi F, Del Rosso A, Manfredi M. Benucci M, et al. Reumatismo. 2005 Apr-Jun;57(2):103-8. doi: 10.4081/reumatismo.2005.103. Reumatismo. 2005. PMID: 15983633 Free article. Italian.

4

Systemic lupus erythematosus (SLE) in Italy: an Italian prevalence study based on a two-step strategy in an area of Florence (Scandicci-Le Signe).

Benucci M, Del Rosso A, Li Gobbi F, Manfredi M, Cerinic MM, Salvarani C. Benucci M, et al. Med Sci Monit. 2005 Sep;11(9):CR420-5. Epub 2005 Aug 26. Med Sci Monit. 2005. PMID: 16127360

5

[Peripheral mononuclear cells and cytokine circulating levels during adalimumab therapy in patients with rheumatoid arthritis].

Benucci M, Li Gobbi F, Fossi F, Cammelli E, Manfredi M. Benucci M, et al. Recenti Prog Med. 2005 Sep;96(9):424-7. Recenti Prog Med. 2005. PMID: 16229322 Italian.

6

Drug-induced lupus after treatment with infliximab in rheumatoid arthritis.

Benucci M, Li Gobbi F, Fossi F, Manfredi M, Del Rosso A. Benucci M, et al. J Clin Rheumatol. 2005 Feb;11(1):47-9. doi: 10.1097/01.rhu.0000152148.55133.ba. J Clin Rheumatol. 2005. PMID: 16357696

7

[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].

Benucci M, Dolenti S, Saviola G, Manfredi M. Benucci M, et al. Recenti Prog Med. 2006 Jan;97(1):24-7. Recenti Prog Med. 2006. PMID: 16535926 Clinical Trial. Italian.

8

[Secondary amyloidosis complicated rheumatoid arthritis, prevalence study in Italian population].

Benucci M, Maniscalchi F, Manfredi M. Benucci M, et al. Recenti Prog Med. 2007 Jan;98(1):16-9. Recenti Prog Med. 2007. PMID: 17345875 Italian.

9

Hypersensitivity reactions to biological agents with special emphasis on tumor necrosis factor-alpha antagonists.

Campi P, Benucci M, Manfredi M, Demoly P. Campi P, et al. Among authors: benucci m. Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):393-403. doi: 10.1097/ACI.0b013e3282ef96df. Curr Opin Allergy Clin Immunol. 2007. PMID: 17873578 Review.

10

Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.

Benucci M, Saviola G, Baiardi P, Cammelli E, Manfredi M. Benucci M, et al. Clin Rheumatol. 2008 Jan;27(1):91-5. doi: 10.1007/s10067-007-0728-5. Epub 2007 Oct 10. Clin Rheumatol. 2008. PMID: 17929076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters